Remdesivir, an experimental anti-viral drug, is showing signs in clinical trials that it could help COVID-19 patients. Jackson Proskow explains what the drug is, and why it’s not a cure.
- Health Canada authorizes remdesivir to treat severe COVID-19
- Experts slam U.S. for hoarding world’s supply of remdesivir — only licensed COVID-19 drug
- Remdesivir has emerged as a possible COVID-19 treatment — what happens next?